GlassScriptPhysician profile
Narsing Rao
NPI 1841368636
$675.61
in general payments reported to CMS, 2019-2025
14 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $98.82 · 2021: $14.04 · 2023: $136 · 2024: $200 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sonex Health, INC. | $166.67 | 2025 | Sx-One Microknife |
| Gilead Sciences, INC. | $71.84 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $71.56 | 2019-2023 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $61.59 | 2019-2025 | Farxiga, Lokelma |
| Inari Medical, INC. | $60.49 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amgen INC. | $45.41 | 2024-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.23 | 2019-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $29.87 | 2024 | |
| Smith+Nephew, INC. | $28.07 | 2021-2024 | Collagenase Santyl |
| Kestra Medical Technology Services, INC. | $27.72 | 2024 | Assure Wcd |
| Boston Scientific Corporation | $26.48 | 2019 | |
| Mallinckrodt Hospital Products INC. | $18.71 | 2024 | Terlivaz |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.69 | 2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $15.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Narsing Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.